DRUG
Bright Minds Biosciences Inc. NASDAQ$83.26
After hrs
$84.56
-1.93%
Mkt Cap $646.2M
52w Low $23.18
59.7% of range
52w High $123.75
50d MA $80.78
200d MA $66.31
P/E (TTM)
-48.9x
EV/EBITDA
-35.9x
P/B
7.3x
Debt/Equity
0.0x
ROE
—
P/FCF
-66.8x
RSI (14)
—
ATR (14)
—
Beta
-0.11
50d MA
$80.78
200d MA
$66.31
Avg Volume
145.0K
About
Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the trea…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | AMC | -0.98 | -0.70 | +28.6% | 80.57 | +0.3% | -3.3% | +4.1% | -0.3% | +6.8% | +6.1% | — |
| Dec 23, 2025 | AMC | -0.56 | -0.41 | +27.1% | 84.27 | +0.5% | +0.5% | -2.6% | -7.3% | -10.0% | -7.4% | — |
| Aug 14, 2025 | AMC | -0.59 | -0.53 | +10.2% | 42.54 | +2.1% | -1.7% | +7.1% | +0.2% | +1.1% | -1.0% | — |
| Feb 13, 2025 | AMC | -0.23 | 0.01 | +104.3% | 45.72 | -1.7% | -8.6% | -18.0% | -18.2% | -20.9% | -21.3% | — |
| Dec 30, 2024 | AMC | -0.44 | -0.12 | +72.9% | 36.86 | +2.3% | -2.3% | +11.5% | +8.1% | +12.3% | +9.1% | — |
| Aug 14, 2024 | AMC | — | 0.04 | — | 1.01 | +4.0% | +2.0% | +5.9% | +1.0% | +0.0% | +2.0% | — |
| May 15, 2024 | AMC | — | -0.10 | — | 1.09 | +0.9% | -2.8% | +0.9% | +0.0% | +11.9% | +3.7% | — |
| Feb 12, 2024 | AMC | — | -0.32 | — | 1.90 | +4.2% | +1.6% | +3.2% | +3.2% | +2.6% | -1.6% | — |
| Dec 29, 2023 | AMC | — | -0.30 | — | 1.43 | +4.2% | +28.7% | +16.8% | +19.6% | +18.9% | +31.5% | — |
| Aug 14, 2023 | AMC | — | -0.29 | — | 2.42 | -2.5% | +9.5% | +6.6% | +6.2% | +8.7% | +7.9% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30 | BTIG | Maintains | Buy → Buy | — | $70.10 | $70.89 | +1.1% | -2.4% | +4.1% | +2.3% | +1.9% | +7.0% |
| Mar 4 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $80.00 | $80.00 | +0.0% | -0.9% | -2.8% | -3.9% | +0.6% | -0.5% |
| Feb 17 | BTIG | Maintains | Buy → Buy | — | $77.90 | $77.60 | -0.4% | +7.7% | +3.1% | +10.5% | +9.7% | +11.0% |
| Jan 7 | BTIG | Maintains | Buy → Buy | — | $93.21 | $91.64 | -1.7% | +3.0% | -3.4% | -6.9% | -4.9% | -4.1% |
| Jan 6 | BTIG | Maintains | Buy → Buy | — | $80.01 | $119.80 | +49.7% | +16.5% | +20.0% | +12.5% | +8.4% | +10.8% |
| Jan 2 | Chardan Capital | Maintains | Buy → Buy | — | $78.04 | $79.51 | +1.9% | +6.9% | +2.5% | +19.4% | +23.0% | +15.3% |
| Dec 30 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $78.12 | $78.26 | +0.2% | -2.9% | -0.1% | +6.8% | +2.4% | +19.3% |
| Sep 15 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $48.75 | $48.80 | +0.1% | -0.2% | -6.8% | -8.3% | +2.9% | +9.3% |
| Aug 19 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $45.55 | $46.13 | +1.3% | -6.4% | -5.6% | -7.5% | -3.5% | -8.5% |
| May 21 | Chardan Capital | Maintains | Buy → Buy | — | $32.46 | $32.10 | -1.1% | -6.3% | -6.9% | -10.6% | -15.5% | -15.7% |
Data updated apr 25, 2026 5:48am
· Source: massive.com